Institutions, research teams, non-profit organizations join forces in novel approaches targeting pancreatic cancer, glioblastoma.
CAMBRIDGE, Mass.–(ENEWSPF)–March 6, 2012. The David H. Koch Institute for Integrative Cancer Research at MIT and Dana-Farber/Harvard Cancer Center (DF/HCC) announced today that they have funded several research teams in a joint collaboration aimed at solving the most intractable challenges in cancer.
The Bridge Project — an unprecedented clinical research collaboration between MIT and DF/HCC — has awarded grants to four…
